214 related articles for article (PubMed ID: 16782733)
41. Economic impact of juvenile idiopathic arthritis.
Bernatsky S; Duffy C; Malleson P; Feldman DE; St Pierre Y; Clarke AE
Arthritis Rheum; 2007 Feb; 57(1):44-8. PubMed ID: 17266088
[TBL] [Abstract][Full Text] [Related]
42. Responsiveness of clinical measures to flare of disease activity in juvenile idiopathic arthritis.
Magni-Manzoni S; Cugno C; Pistorio A; Garay S; Tsitsami E; Gasparini C; Viola S; Ruperto N; Martini A; Ravelli A
Clin Exp Rheumatol; 2005; 23(3):421-5. PubMed ID: 15971436
[TBL] [Abstract][Full Text] [Related]
43. Health-related quality of life, physical function, fatigue, and disease activity in children with established polyarticular juvenile idiopathic arthritis.
Ringold S; Wallace CA; Rivara FP
J Rheumatol; 2009 Jun; 36(6):1330-6. PubMed ID: 19411394
[TBL] [Abstract][Full Text] [Related]
44. Cartilage oligomeric matrix protein in patients with juvenile idiopathic arthritis: relation to growth and disease activity.
Bjørnhart B; Juul A; Nielsen S; Zak M; Svenningsen P; Müller K
J Rheumatol; 2009 Aug; 36(8):1749-54. PubMed ID: 19605679
[TBL] [Abstract][Full Text] [Related]
45. Relationship between health-related quality of life and SLE activity and damage in children over time.
Moorthy LN; Peterson MG; Hassett AL; Baratelli M; Chalom EC; Hashkes PJ; Hong S; Reiff A; Lehman TJ
Lupus; 2009 Jun; 18(7):622-9. PubMed ID: 19433463
[TBL] [Abstract][Full Text] [Related]
46. Outcome in patients with enthesitis related arthritis (ERA): juvenile arthritis damage index (JADI) and functional status.
Sarma PK; Misra R; Aggarwal A
Pediatr Rheumatol Online J; 2008 Oct; 6():18. PubMed ID: 18945336
[TBL] [Abstract][Full Text] [Related]
47. Severity of asthma: parent's assessment versus the physician's.
Ben-Noun L
Practitioner; 1989 Aug; 233(1473):1052. PubMed ID: 2602327
[No Abstract] [Full Text] [Related]
48. Assessing current outcomes of juvenile idiopathic arthritis: a cross-sectional study in a tertiary center sample.
Solari N; Viola S; Pistorio A; Magni-Manzoni S; Vitale R; Ruperto N; Ullmann N; Filocamo G; Martini A; Ravelli A
Arthritis Rheum; 2008 Nov; 59(11):1571-9. PubMed ID: 18975357
[TBL] [Abstract][Full Text] [Related]
49. Parent and child acceptable symptom state in juvenile idiopathic arthritis.
Filocamo G; Consolaro A; Schiappapietra B; Ruperto N; Pistorio A; Solari N; Pederzoli S; Verazza S; Martini A; Ravelli A
J Rheumatol; 2012 Apr; 39(4):856-63. PubMed ID: 22298905
[TBL] [Abstract][Full Text] [Related]
50. What factors affect discordance between physicians and patients in the global assessment of disease activity in rheumatoid arthritis?
Cho SK; Sung YK; Choi CB; Bang SY; Cha HS; Choe JY; Chung WT; Hong SJ; Jun JB; Kim J; Kim TH; Kim TJ; Koh EM; Lee HS; Lee J; Lee SH; Lee SS; Lee SW; Park SH; Yoo DH; Yoon BY; Bae SC;
Mod Rheumatol; 2017 Jan; 27(1):35-41. PubMed ID: 27143194
[TBL] [Abstract][Full Text] [Related]
51. Pain in children with juvenile rheumatoid arthritis: a descriptive study.
Abu-Saad HH; Uiterwijk M
Pediatr Res; 1995 Aug; 38(2):194-7. PubMed ID: 7478815
[TBL] [Abstract][Full Text] [Related]
52. HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis.
Berntson L; Damgård M; Andersson-Gäre B; Herlin T; Nielsen S; Nordal E; Rygg M; Zak M; Fasth A;
J Rheumatol; 2008 Oct; 35(10):2055-61. PubMed ID: 18785306
[TBL] [Abstract][Full Text] [Related]
53. Achievement of a state of inactive disease at least once in the first 5 years predicts better outcome of patients with polyarticular juvenile idiopathic arthritis.
Magnani A; Pistorio A; Magni-Manzoni S; Falcone A; Lombardini G; Bandeira M; Rossi F; Sala I; Martini A; Ravelli A
J Rheumatol; 2009 Mar; 36(3):628-34. PubMed ID: 19208600
[TBL] [Abstract][Full Text] [Related]
54. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis.
Céspedes-Cruz A; Gutiérrez-Suárez R; Pistorio A; Ravelli A; Loy A; Murray KJ; Gerloni V; Wulffraat N; Oliveira S; Walsh J; Penades IC; Alpigiani MG; Lahdenne P; Saad-Magalhães C; Cortis E; Lepore L; Kimura Y; Wouters C; Martini A; Ruperto N;
Ann Rheum Dis; 2008 Mar; 67(3):309-14. PubMed ID: 17875547
[TBL] [Abstract][Full Text] [Related]
55. Discordance between proxy-reported and observed assessment of functional ability of children with juvenile idiopathic arthritis.
Ravelli A; Viola S; Migliavacca D; Pistorio A; Ruperto N; Martini A
Rheumatology (Oxford); 2001 Aug; 40(8):914-9. PubMed ID: 11511761
[TBL] [Abstract][Full Text] [Related]
56. Perceived adherence to prescribed treatment in juvenile idiopathic arthritis over a one-year period.
Feldman DE; de Civita M; Dobkin PL; Malleson P; Meshefedjian G; Duffy CM
Arthritis Rheum; 2007 Mar; 57(2):226-33. PubMed ID: 17330298
[TBL] [Abstract][Full Text] [Related]
57. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.
Prince FH; Twilt M; ten Cate R; van Rossum MA; Armbrust W; Hoppenreijs EP; van Santen-Hoeufft M; Koopman-Keemink Y; Wulffraat NM; van Suijlekom-Smit LW
Ann Rheum Dis; 2009 May; 68(5):635-41. PubMed ID: 18413443
[TBL] [Abstract][Full Text] [Related]
58. A new disease activity index for rheumatoid arthritis: Mean Overall Index for Rheumatoid Arthritis (MOI-RA).
Mäkinen H; Kautiainen H; Hannonen P; Sokka T
J Rheumatol; 2008 Aug; 35(8):1522-7. PubMed ID: 18484699
[TBL] [Abstract][Full Text] [Related]
59. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
Biederman J; Melmed RD; Patel A; McBurnett K; Konow J; Lyne A; Scherer N;
Pediatrics; 2008 Jan; 121(1):e73-84. PubMed ID: 18166547
[TBL] [Abstract][Full Text] [Related]
60. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.
Habib HM; Mosaad YM; Youssef HM
Immunol Invest; 2008; 37(8):849-57. PubMed ID: 18991100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
